Autres langues GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.

Actions

GLAXO

INE159A01016

Produits pharmaceutiques

Marché Fermé - NSE India S.E. 13:05:08 21/09/2026			Varia. 5j.	Varia. 1 janv.
2 862,90 ^INR	+0,85 %		+1,22 %	+15,74 %

03/08	GSK India : le bénéfice du premier trimestre progresse grâce à la demande soutenue de vaccins	RE
03/08	GlaxoSmithKline Pharmaceuticals Limited publie ses résultats pour le premier trimestre clos le 30 juin 2026	CI

Autres langues

03/08	GSK India first-quarter profit rises on steady vaccine demand
03/08	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
03/08	Glaxosmithkline Pharmaceuticals Limited Announces Management Changes
09/07	Delhi High Court Declares GSK’s ‘CALPOL’ A Well-Known Trademark
29/05	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026
13/05	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit
13/05	GlaxoSmithKline Pharmaceuticals March-quarter consol profit 2.78 billion rupees
13/05	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2026
13/05	GlaxoSmithKline Pharmaceuticals Limited announces Annual dividend, payable on July 30, 2026
21/04	Glaxosmithkline Pharmaceuticals Limited Announces Appointment of Vinay Subramanian as Commercial Head ? Oncology and Senior Management Personnel, Effective April 20, 2026
31/03	GlaxoSmithKline Pharmaceuticals receives TDS demand liability of 20.1 million rupees
24/03	GlaxoSmithKline Pharmaceuticals Ltd receives final order with tax demand liability of 232.1 mln rupees for AY 2023-24
16/03	GlaxoSmithKline Pharmaceuticals Ltd says Juby Chandy resigns as whole-time director and CFO
02/03	GlaxoSmithKline Pharmaceuticals Names CFO
02/03	GlaxoSmithKline Pharmaceuticals says Ronojit Biswas appointed as whole-time director & CFO
02/03	GlaxoSmithKline Pharmaceuticals Limited Announces Chief Financial Officer Changes
02/03	GlaxoSmithKline Pharmaceuticals Limited Announces Executive Changes
23/02	GlaxoSmithKline Pharmaceuticals gets order with total tax demand of 37.9 million rupees including tax, penalty
09/02	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
09/02	GlaxoSmithKline Pharmaceuticals Ltd Dec-quarter consol profit 2.96 billion rupees
31/12	GlaxoSmithKline Pharmaceuticals gets tax demand of 85.7 million rupees
22/12	GlaxoSmithKline Pharmaceuticals Ltd receives tax demand order of 9 million rupees
06/11	GlaxoSmithKline India reports higher second-quarter profit on specialty medicine growth
06/11	GlaxoSmithKline Pharma Q2 consol profit 2.57 billion rupees
29/10/25	GlaxoSmithKline Pharmaceuticals Limited Announces Resumption Of Sukanya Choudhury As Executive Vice President - Regulatory Affairs